Invitrogen™ Human LGI1 Synthetic Peptide
LGI1 Synthetic Peptide, PEP-0611, from Invitrogen.
- Gene ID (Enter)
- 9211
- Species
- Human
- Purification method
- Purified
- Accession number
- O95970
- Common name
- Human LGI1
- Brand
- Invitrogen
LGI1 Synthetic Peptide, PEP-0611, from Invitrogen.
LGI1 Synthetic Peptide, PEP-0611, from Invitrogen.
The leucine-rich, glioma inactivated gene 1 (LGI1) was first identified as a candidate tumor suppressor gene for glioma and may play a role in other cancers. LGI1 is a member of a family of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 serves as a ligand to ADAM22, a metalloprotease localized at the synapse. Mutations in LGI1 account for nearly half of autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Two isoforms of LGI1 are known to exist.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15338770 |
| Specifications | |
| Gene ID (Enter) | 9211 |
| Species | Human |
| Purification method | Purified |
| Accession number | O95970 |
| Common name | Human LGI1 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | LGI1 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-0611 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |